View in EDS

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Saved in:
Bibliographic Details
Title: Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
Authors: Rugo HS; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. Electronic address: hrugo@medicine.ucsf.edu., Pritchard KI; Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada., Gnant M; Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Noguchi S; Department of Breast and Endocrine Surgery, Osaka University, Osaka, Japan., Piccart M; Institut Jules Bordet, Brussels, Belgium., Hortobagyi G; The University of Texas MD Anderson Cancer Center, Houston., Baselga J; Memorial Sloan-Kettering Cancer Center, New York., Perez A; Memorial Cancer Institute, Hollywood, USA., Geberth M; Praxisklinic am Rosengarten Mannheim, Schwerpunktpraxis für Gynaekologische Onkologie, Mannheim, Germany., Csoszi T; Department of Medical Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary., Chouinard E; Cambridge Memorial Hospital, Cambridge, Canada., Srimuninnimit V; Siriraj Hospital, Mahidol University, Bangkok., Puttawibul P; Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand., Eakle J; Florida Cancer Specialists, Ft Myers., Feng W; Novartis Pharmaceuticals Corporation, East Hanover, USA., Bauly H; Novartis Pharma AG, Basel, Switzerland., El-Hashimy M; Novartis Pharmaceuticals Corporation, East Hanover, USA., Taran T; Novartis Pharmaceuticals Corporation, East Hanover, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, USA.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Apr; Vol. 25 (4), pp. 808-815. Date of Electronic Publication: 2014 Mar 10.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24615500
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA. Electronic address: hrugo@medicine.ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Pritchard+KI%22">Pritchard KI</searchLink>; Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Gnant+M%22">Gnant M</searchLink>; Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Noguchi+S%22">Noguchi S</searchLink>; Department of Breast and Endocrine Surgery, Osaka University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Piccart+M%22">Piccart M</searchLink>; Institut Jules Bordet, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Hortobagyi+G%22">Hortobagyi G</searchLink>; The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Baselga+J%22">Baselga J</searchLink>; Memorial Sloan-Kettering Cancer Center, New York.<br /><searchLink fieldCode="AU" term="%22Perez+A%22">Perez A</searchLink>; Memorial Cancer Institute, Hollywood, USA.<br /><searchLink fieldCode="AU" term="%22Geberth+M%22">Geberth M</searchLink>; Praxisklinic am Rosengarten Mannheim, Schwerpunktpraxis für Gynaekologische Onkologie, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Csoszi+T%22">Csoszi T</searchLink>; Department of Medical Oncology, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary.<br /><searchLink fieldCode="AU" term="%22Chouinard+E%22">Chouinard E</searchLink>; Cambridge Memorial Hospital, Cambridge, Canada.<br /><searchLink fieldCode="AU" term="%22Srimuninnimit+V%22">Srimuninnimit V</searchLink>; Siriraj Hospital, Mahidol University, Bangkok.<br /><searchLink fieldCode="AU" term="%22Puttawibul+P%22">Puttawibul P</searchLink>; Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.<br /><searchLink fieldCode="AU" term="%22Eakle+J%22">Eakle J</searchLink>; Florida Cancer Specialists, Ft Myers.<br /><searchLink fieldCode="AU" term="%22Feng+W%22">Feng W</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, USA.<br /><searchLink fieldCode="AU" term="%22Bauly+H%22">Bauly H</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22El-Hashimy+M%22">El-Hashimy M</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, USA.<br /><searchLink fieldCode="AU" term="%22Taran+T%22">Taran T</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, USA.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute, Nashville, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2014 Apr; Vol. 25 (4), pp. 808-815. <i>Date of Electronic Publication: </i>2014 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24615500
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdu009
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 808
    Titles:
      – TitleFull: Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Pritchard KI
      – PersonEntity:
          Name:
            NameFull: Gnant M
      – PersonEntity:
          Name:
            NameFull: Noguchi S
      – PersonEntity:
          Name:
            NameFull: Piccart M
      – PersonEntity:
          Name:
            NameFull: Hortobagyi G
      – PersonEntity:
          Name:
            NameFull: Baselga J
      – PersonEntity:
          Name:
            NameFull: Perez A
      – PersonEntity:
          Name:
            NameFull: Geberth M
      – PersonEntity:
          Name:
            NameFull: Csoszi T
      – PersonEntity:
          Name:
            NameFull: Chouinard E
      – PersonEntity:
          Name:
            NameFull: Srimuninnimit V
      – PersonEntity:
          Name:
            NameFull: Puttawibul P
      – PersonEntity:
          Name:
            NameFull: Eakle J
      – PersonEntity:
          Name:
            NameFull: Feng W
      – PersonEntity:
          Name:
            NameFull: Bauly H
      – PersonEntity:
          Name:
            NameFull: El-Hashimy M
      – PersonEntity:
          Name:
            NameFull: Taran T
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2014 Apr
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1